Women and men are not receiving effective diagnostic testing and 
      treatments of osteoporosis, a life threatening condition affecting 
      millions of Americans, according to an expert today at the American 
      Association of Clinical Endocrinologists (AACE) 21st Annual 
      Meeting & Clinical Congress in Philadelphia.
    
Osteoporosis is responsible for approximately 300,000 annual hospital 
      admissions for hip fractures, with estimates exceeding 500,000 by the 
      year 2040, according to the Center for Disease Control. 
      "Although the practice of managing osteoporosis has made significant 
      progress in both diagnosis and treatment tools during the past 20 years, 
      implementing effective treatment strategies into clinical practice is 
      lacking," said Dr. Michael McClung, MD, FACE, and Director of the Oregon 
      Osteoporosis Center in Portland.
    
    
      Clinical scientists have made substantial advances in recent years in 
      understanding osteoporosis, as well as its impact on certain 
      populations. Accordingly, medical practitioners now have very effective 
      tools to identify men and women with osteoporosis and those who are at 
      risk for fractures, according to Dr. McClung, as well as an array of 
      treatment options to effectively decrease fracture risks. Further, 
      evidence-based guidelines are available to guide practice management, 
      including the AACE 
      Guidelines on Osteoporosis.
    
    
      "However, the advances made in our clinical studies are often not put 
      into practice in the clinics of our country," said Dr. McClung. "Many 
      primary care physicians are unaware that national guidelines for the 
      treatment of osteoporosis exist and therefore fail to utilize them as 
      resources. Additionally, patients and many physicians are reluctant to 
      treat osteoporosis with pharmacological agents because they are so 
      concerned about the rare side effects."
    
    
      The challenge for all clinicians, Dr. McClung said, is to translate the 
      available clinical science regarding osteoporosis management into 
      regular clinical practice on a daily basis.
    
    
      "Endocrinologists are experts who effectively treat osteoporosis, but we 
      need to take advantage of opportunities to help our clinical colleagues 
      be more comfortable with managing their patients with this condition," 
      said Dr. McClung. "We need to share knowledge about the guidelines for 
      testing and treating, as well as provide a clear perspective on the 
      relationship between the benefits of treatment and the very uncommon 
      associated risks."